iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-02 |
2024-03 |
-0.99 |
-1.47 |
-0.48 |
-48.48% |
2024-02-22 |
2023-12 |
-0.6 |
-1.26 |
-0.66 |
-110.00% |
2023-11-02 |
2023-09 |
-0.65 |
-0.89 |
-0.24 |
-36.92% |
2023-08-03 |
2023-06 |
-0.75 |
-0.61 |
0.14 |
18.67% |
2023-05-04 |
2023-03 |
-0.8 |
-1.29 |
-0.49 |
-61.25% |
2023-02-23 |
2022-12 |
-0.63 |
-0.67 |
-0.04 |
-6.35% |
Date |
Firm |
Action |
From |
To |
2023-10-10 |
Morgan Stanley |
Upgrade |
Overweight |
Overweight |
2023-08-27 |
Canaccord Genuity |
Upgrade |
Buy |
Buy |
2023-08-06 |
Truist Securities |
Upgrade |
Buy |
Buy |
2023-08-03 |
Needham |
Upgrade |
Buy |
Buy |
2023-08-03 |
Morgan Stanley |
Upgrade |
Overweight |
Overweight |
2023-07-18 |
Baird |
Upgrade |
|
Outperform |
Date |
Name |
Relation |
Quantity |
Description |
2024-03-03 |
BLACKFORD QUENTIN S |
Chief Executive Officer |
175.79K |
Sale |
2024-03-03 |
BOBZIEN BRICE |
Chief Financial Officer |
25.80K |
Sale |
2024-03-03 |
DAY MARK J |
Chief Technology Officer |
61.16K |
Sale |
2024-03-03 |
MURPHY PATRICK MICHAEL |
Officer |
47.44K |
Sale |
2024-03-03 |
PATTERSON CHAD |
Officer |
39.87K |
Sale |
2024-02-27 |
ROSENBAUM MARK W |
Officer |
8.68K |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Group Inc |
2.93M |
305.79M |
9.59% |
2023-06-29 |
Sands Capital Management, LLC |
2.39M |
248.97M |
7.81% |
2023-06-29 |
Blackrock Inc. |
2.37M |
247.58M |
7.76% |
2023-06-29 |
Capital Research Global Investors |
2.29M |
238.73M |
7.48% |
2023-06-29 |
FMR, LLC |
1.62M |
168.55M |
5.28% |
2023-06-29 |
Artisan Partners Limited Partnership |
1.60M |
167.20M |
5.24% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Smallcap World Fund |
1.45M |
151.68M |
4.75% |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
893.32K |
93.19M |
2.92% |
2023-06-29 |
Vanguard Small-Cap Index Fund |
747.33K |
77.96M |
2.44% |
2023-08-30 |
iShares Russell 2000 ETF |
699.48K |
72.31M |
2.29% |
2023-06-29 |
New Economy Fund (The) |
681.61K |
71.11M |
2.23% |
2023-05-30 |
Fidelity Select Portfolios - Medical Technology & Devices Port |
600.00K |
68.56M |
1.96% |